Back to Browse Journals » International Journal of Nephrology and Renovascular Disease » Volume 7

Obesity, hypertension, and chronic kidney disease

Authors Hall ME, do Carmo JM, da Silva AA, Juncos LA, Wang Z, Hall JE

Received 25 October 2013

Accepted for publication 4 December 2013

Published 18 February 2014 Volume 2014:7 Pages 75—88


Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Michael E Hall,1,2 Jussara M do Carmo,2 Alexandre A da Silva,2 Luis A Juncos,1,2 Zhen Wang,2 John E Hall2

1Department of Medicine, 2Department of Physiology and Biophysics, Mississippi Center for Obesity Research, University of Mississippi Medical Center, Jackson, MS, USA

Abstract: Obesity is a major risk factor for essential hypertension, diabetes, and other comorbid conditions that contribute to development of chronic kidney disease. Obesity raises blood pressure by increasing renal tubular sodium reabsorption, impairing pressure natriuresis, and causing volume expansion via activation of the sympathetic nervous system and renin-angiotensin-aldosterone system and by physical compression of the kidneys, especially when there is increased visceral adiposity. Other factors such as inflammation, oxidative stress, and lipotoxicity may also contribute to obesity-mediated hypertension and renal dysfunction. Initially, obesity causes renal vasodilation and glomerular hyperfiltration, which act as compensatory mechanisms to maintain sodium balance despite increased tubular reabsorption. However, these compensations, along with increased arterial pressure and metabolic abnormalities, may ultimately lead to glomerular injury and initiate a slowly developing vicious cycle that exacerbates hypertension and worsens renal injury. Body weight reduction, via caloric restriction and increased physical activity, is an important first step for management of obesity, hypertension, and chronic kidney disease. However, this strategy may not be effective in producing long-term weight loss or in preventing cardiorenal and metabolic consequences in many obese patients. The majority of obese patients require medical therapy for obesity-associated hypertension, metabolic disorders, and renal disease, and morbidly obese patients may require surgical interventions to produce sustained weight loss.

Keywords: visceral adiposity, type II diabetes, sodium reabsorption, glomerular filtration rate, sympathetic nervous system, renin-angiotensin-aldosterone system

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at:

Readers of this article also read:

HCA519/TPX2: a potential T-cell tumor-associated antigen for human hepatocellular carcinoma

Aref AM, Hoa NT, Ge L, Agrawal A, Dacosta-Iyer M, Lambrecht N, Ouyang Y, Cornforth AN, Jadus MR

OncoTargets and Therapy 2014, 7:1061-1070

Published Date: 13 June 2014

Cigarette smoking and colorectal cancer mortality among 602,242 Norwegian males and females

Parajuli R, Bjerkaas E, Tverdal A, Le Marchand L, Weiderpass E, Gram IT

Clinical Epidemiology 2014, 6:137-145

Published Date: 7 April 2014

Spontaneous bacterial peritonitis with a very high leukocyte count in ascitic fluid caused by Haemophilus influenzae

Saadi T, Khoury S, Veitsman E, Baruch Y, Raz-Pasteur A

International Journal of General Medicine 2013, 6:689-691

Published Date: 19 August 2013

The natural history of ulcerative colitis in a pediatric population: a follow-up population- based cohort study

Malaty HM, Abraham BP, Mehta S, Garnett EA, Ferry GD

Clinical and Experimental Gastroenterology 2013, 6:77-83

Published Date: 17 June 2013

Respiratory syncytial virus induces functional thymic stromal lymphopoietin receptor in airway epithelial cells

Miazgowicz MM, Elliott MS, Debley JS, Ziegler SF

Journal of Inflammation Research 2013, 6:53-61

Published Date: 24 March 2013

Estrogen formulations and beauty care practices in Japanese women

Takeda T, Wong TF, Kitamura M, Yaegashi N

International Journal of Women's Health 2012, 4:19-24

Published Date: 31 January 2012

Thioperamide induces CD4+ CD25+ Foxp3+ regulatory T lymphocytes in the lung mucosa of allergic mice through its action on dendritic cells

Amaral MM, Alvarez CA, Langellotti C, Jancic C, Salamone G, Geffner J, Vermeulen M

Journal of Asthma and Allergy 2011, 4:93-102

Published Date: 26 September 2011

Arterial pulmonary hypertension in noncardiac intensive care unit

Mykola V Tsapenko, Arseniy V Tsapenko, Thomas BO Comfere, Girish K Mour, Sunil V Mankad, Ognjen Gajic

Vascular Health and Risk Management 2008, 4:1043-1060

Published Date: 10 October 2008

Intravitreal triamcinolone acetonide: Pattern of secondary intraocular pressure rise and possible risk factors

Ziad F Bashshur, Abdallah M Terro, Christelle P El Haibi, Akaber M Halawi, Alexandre Schakal, Baha’ N Noureddin

Clinical Ophthalmology 2008, 2:269-274

Published Date: 6 June 2008

Isosorbide dinitrate-hydralazine combination therapy in African Americans with heart failure

Melvin R Echols, Clyde W Yancy

Vascular Health and Risk Management 2006, 2:423-431

Published Date: 15 December 2006